Latest news with #AOM
Business Wire
22-05-2025
- Business
- Business Wire
May 2025 Meeting: Port Houston Announces $131 Million in USACE Workplan Designated for Houston Ship Channel Construction and Maintenance
HOUSTON--(BUSINESS WIRE)--On Tuesday, May 20, the Port Commission of the Port of Houston Authority met for its regular monthly meeting. Chairman Ric Campo opened the meeting with an update that the U.S. Army Corps of Engineers (USACE) released their FY25 workplan, which includes $33 million allocated to the Houston Ship Channel Expansion, known as Project 11, construction and $98 million to operations and maintenance to keep the Houston Ship Channel dredged. 'Thank you to everyone who pulled together to get this done, including our industry partners, customers, congressional delegation, and specifically Congressman Wesley Hunt and Congressman Brian Babin who worked around the clock to make sure we got what we needed,' said Chairman Campo. Port Houston reported strong volumes in April, which can be found in more detail via the press release issued on May 19. Operations reported nine blank sailings forecasted over the next six weeks at the container terminals. Despite this, Port Houston remains cautiously optimistic, noting that the number is significantly lower than during previous periods of market uncertainty, such as the COVID-19 pandemic. It was also announced that the USACE approved the federal Assumption of Maintenance (AOM) for Segment 1B of the Houston Ship Channel (Redfish Reef to Bayport Terminal), in addition to Segment 1C (Bayport to Barbours Cut Ship Channel), which was approved in 2022. This marks the successful conclusion of a nearly five-year group effort and with these approvals Port Houston will save a net present value of nearly $380 million over the next 50 years. The organization is on track to complete the dredging activities in Segment 1C by late Q2/early Q3 2025, completing the Port Houston-led portions of Project 11 dredging. Completion of Galveston Bay beneficial use features is scheduled for Q4 2025. As it relates to maintenance at the public terminals, Port Houston commissioned 20 clean diesel yard tractors at Barbours Cut Terminal and Bayport Terminal, removing 20 outdated, less efficient tractors from service. The organization is also actively collaborating with TxDOT (Texas Department of Transportation), Houston Pilots and PSEO (Port Security and Emergency Operations) to temporarily improve air draft markings on the Interstate 610 bridge. Additional Meeting Updates & Announcements Port Houston CEO Charlie Jenkins highlighted the Maritime Museum's upcoming grand opening at their new location next to Port Houston's Administrative Building at East River. Port Houston will be a sponsor for the new space. Chairman Campo also congratulated the 2025 maritime program graduates, noting that Port Houston's maritime education program and ongoing partnerships with industry and area schools and universities further bolsters the port's talent pipeline and contributes to the future maritime workforce. The Port Commission meets next on Tuesday, June 24, 2025. About Port Houston For more than 100 years, Port Houston has owned and operated the public wharves and terminals along the Houston Ship Channel, including the area's largest breakbulk facility and two of the most efficient container terminals in the country. Port Houston is the advocate and a strategic leader for the Channel. The Houston Ship Channel complex and its more than 200 private and eight public terminals is the nation's largest port for waterborne tonnage and an essential economic engine for the Houston region, the state of Texas and the U.S. The Port of Houston supports the creation of nearly 1.5 million jobs in Texas and 3.37 million jobs nationwide, and economic activity totaling $439 billion in Texas and $906 billion in economic impact across the nation. For more information, visit the website at
Yahoo
22-05-2025
- Business
- Yahoo
May 2025 Meeting: Port Houston Announces $131 Million in USACE Workplan Designated for Houston Ship Channel Construction and Maintenance
HOUSTON, May 22, 2025--(BUSINESS WIRE)--On Tuesday, May 20, the Port Commission of the Port of Houston Authority met for its regular monthly meeting. Chairman Ric Campo opened the meeting with an update that the U.S. Army Corps of Engineers (USACE) released their FY25 workplan, which includes $33 million allocated to the Houston Ship Channel Expansion, known as Project 11, construction and $98 million to operations and maintenance to keep the Houston Ship Channel dredged. "Thank you to everyone who pulled together to get this done, including our industry partners, customers, congressional delegation, and specifically Congressman Wesley Hunt and Congressman Brian Babin who worked around the clock to make sure we got what we needed," said Chairman Campo. Project 11 Updates & Operations Highlights Port Houston reported strong volumes in April, which can be found in more detail via the press release issued on May 19. Operations reported nine blank sailings forecasted over the next six weeks at the container terminals. Despite this, Port Houston remains cautiously optimistic, noting that the number is significantly lower than during previous periods of market uncertainty, such as the COVID-19 pandemic. It was also announced that the USACE approved the federal Assumption of Maintenance (AOM) for Segment 1B of the Houston Ship Channel (Redfish Reef to Bayport Terminal), in addition to Segment 1C (Bayport to Barbours Cut Ship Channel), which was approved in 2022. This marks the successful conclusion of a nearly five-year group effort and with these approvals Port Houston will save a net present value of nearly $380 million over the next 50 years. The organization is on track to complete the dredging activities in Segment 1C by late Q2/early Q3 2025, completing the Port Houston-led portions of Project 11 dredging. Completion of Galveston Bay beneficial use features is scheduled for Q4 2025. As it relates to maintenance at the public terminals, Port Houston commissioned 20 clean diesel yard tractors at Barbours Cut Terminal and Bayport Terminal, removing 20 outdated, less efficient tractors from service. The organization is also actively collaborating with TxDOT (Texas Department of Transportation), Houston Pilots and PSEO (Port Security and Emergency Operations) to temporarily improve air draft markings on the Interstate 610 bridge. Additional Meeting Updates & Announcements Port Houston CEO Charlie Jenkins highlighted the Maritime Museum's upcoming grand opening at their new location next to Port Houston's Administrative Building at East River. Port Houston will be a sponsor for the new space. Chairman Campo also congratulated the 2025 maritime program graduates, noting that Port Houston's maritime education program and ongoing partnerships with industry and area schools and universities further bolsters the port's talent pipeline and contributes to the future maritime workforce. The Port Commission meets next on Tuesday, June 24, 2025. About Port Houston For more than 100 years, Port Houston has owned and operated the public wharves and terminals along the Houston Ship Channel, including the area's largest breakbulk facility and two of the most efficient container terminals in the country. Port Houston is the advocate and a strategic leader for the Channel. The Houston Ship Channel complex and its more than 200 private and eight public terminals is the nation's largest port for waterborne tonnage and an essential economic engine for the Houston region, the state of Texas and the U.S. The Port of Houston supports the creation of nearly 1.5 million jobs in Texas and 3.37 million jobs nationwide, and economic activity totaling $439 billion in Texas and $906 billion in economic impact across the nation. For more information, visit the website at View source version on Contacts Lisa Ashley-Daniels, Director, Public RelationsOffice: 713-670-2644Mobile: 832-247-8179E-mail: lashley@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Miami Herald
07-03-2025
- Health
- Miami Herald
Miami lawmaker pushes for Medicaid, Medicare to cover anti-obesity medicine
For a state of over 23 million people, approximately 40% of the population has one thing in common — they are either Medicare or Medicaid beneficiaries. Across the Sunshine State, just shy of nine million people utilize government health insurance programs. With many individuals in Florida relying on these programs, ensuring they are as comprehensive as possible is key to improving health. For many beneficiaries of these programs, one of the biggest health issues they face is obesity and its various co-morbidities. But just 10% of people with obesity receive any treatment for the disease. In the Florida Legislature, which went into session this week, we're looking to change that. I've introduced legislation, Senate Bill 648, that would expand Medicaid treatment options for obesity, including covering the cost of the use of Food and Drug Administration (FDA) approved anti-obesity medications, known as AOMs. Now, I hope the federal government follows our lead. President Donald Trump has long fought for commonsense healthcare reform. Fortunately, he has a chance to deliver on it. He is reviewing a rule from the Centers for Medicare & Medicaid Services (CMS) which establishes or modifies what Medicare and Medicaid will cover. Only by finalizing this proposed CMS rule and expanding AOM can their full potential be realized in Florida and across the country. It's necessary that Trump finalize it. Obesity is the nation's second leading cause of death and raises an individual's mortality rate from anywhere from 22% to 91%. Not to mention, it's a significant risk factor for the leading cause of death: heart disease. Beyond that, it's connected to over 200 other serious chronic diseases ranging from diabetes to 13 of the most prevalent cancers to arthritis. All told, the impact of obesity on the human body is severe. For years, lifestyle changes, primarily diet and exercise, have been the primary treatment option for obesity. But it's clear that this alone is not the most effective treatment available. For patients who adopt lifestyle changes and nothing else, more than 95% of weight lost is regained within five years. That's where AOMs come into play. AOMs have been proven to be a highly effective tool in treating obesity. Over the last several years, a sizable body of research has shown their benefits, including reduced blood pressure, reduced sleep apnea, improved glycemic health and significant, sustained weight loss. They provide a pathway to weight loss that, in turn, reduces the risk of obesity-related complications. For our state's seniors, reducing obesity can mean a lessened risk of falls, better mental health and a lower chance of nursing home admission, all of which serve to enhance independence. But right now, far too few individuals have access to them. Of the 10% of people who receive any medical help for obesity, a minuscule 2% subset take AOMs. Annually, across the entire U.S. public and private healthcare system, hundreds of billions of dollars are spent on obesity and related illnesses. Looking at the Medicare and Medicaid programs alone, that figure is beginning to encroach on $100 billion a year. The link between obesity and other chronic diseases is clear and lead down the same path — more hospitalizations, more deaths and higher annual medical costs. On the flip side, the broader use of AOMs, particularly among Medicare and Medicaid recipients, has a clear line to fewer medical costs in treating obesity and related conditions. The more effective treatment of obesity through Medicare and Medicaid could lead to net savings of over $700 billion over the next 30 years. Obesity is one of our nation's biggest public health crises, and AOMs are a pivotal innovation in the healthcare space as we look to solve it. Only by finalizing this proposed CMS rule and expanding AOM coverage in Medicare and Medicaid can their full potential be realized. Ana Maria Rodriguez is a Republican state senator representing District 40, which includes parts of southern Miami-Dade and Monroe counties.
Yahoo
29-01-2025
- Business
- Yahoo
Tympanostomy Products Market to Reach $121.88 Million by 2031 Driven by Rising Ear Infections and Technological Advancements
US & Canada, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to a comprehensive report from The Insight Partners, 'Tympanostomy Products Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Tube Applicators/Inserters and Tympanostomy Tubes), Tube Applicators/inserters (Disposable and Reusable), Tympanostomy Tubes (Grommet, Intermediate Ear Tubes, T-Shaped Tubes), Material (Silicone, Fluoroplastic, Titanium, Stainless Steel), Application (Acute Otitis Media, Recurrent Otitis Media with Effusion, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and Geography'. Global tympanostomy products market is observing significant growth owing to the increasing incidence of ear infections along with the rising awareness about ear Sample Report- The report runs an in-depth analysis of market trends, key players, and future opportunities. The tympanostomy products market comprises the analysis of an array of products used for the treatment of ear infections, which are expected to determine the market strength in the coming years. Tympanostomy Products Market Overview of Report Findings Market Growth: The tympanostomy products market value is expected to reach US$ 121.88 million by 2031 from US$ 95.83 million in 2023 at a CAGR of 3.1%. Tympanostomy involves creating an opening in the eardrum to relieve pressure and fluid buildup in the middle ear. This is often done to treat ear infections or to help with chronic ear problems. Ear tubes, small, hollow cylinders made of plastic or metal, are generally used as a tympanostomy product for the effective treatment of ear infections. Surging Incidence of Ear Infections: Ear infections can affect people with weakened immune systems, chronic skin conditions (such as psoriasis), and respiratory tract infections; these conditions are also common in individuals spending a lot of time in water. Otitis media (OM) is a type of ear infection that occurs in the middle ear and can affect the auditory system and ear structure. Children aged less than 6 are frequently affected by OM due to developing immune systems and anatomical structures. According to the article "A Pediatrician Explains a Spike in Ear Infections After COVID-19 Restrictions Lifted," nearly 25% of children suffer from ear infections at the age of 1, whereas ~60% of children suffer from ear infections by the age of 5. As per the article "Effect of Ear Infections on Hearing Ability: A Narrative Review on the Complications of Otitis Media," published in the National Library of Medicine (NLM), the incidence of acute otitis media (AOM) is ~11% globally (i.e., nearly 700 million people) every year. Children account for a huge share of those infected, causing more than 50% of the cases. In all, nearly 31 million people with AOM develop chronic suppurative otitis media (CSOM) each year, including >7 million children. Hearing loss affects more than 50% of individuals with CSOM, i.e., ~0.3% of the global population. Thus, the increasing incidence of ear infections such as OM in children, which may further cause hearing loss, fuels the growth of the tympanostomy products market. Technological Advancements: Tympanostomy tubes that are inserted into the eardrum to provide a route for the drainage of fluid are tiny hollow tubes generally made from plastics and metals; thus, their surfaces act as a substratum for bacterial growth as well as biofilm formation; moreover, bacterial growth on local tissues may lead to the blockage of the tube's lumen. The insertion of tubes into the eardrum is associated with the possibility that the antibiotic ear drops prescribed for infection may not reach their site of action. As a result, companies are focusing on developing technologically advanced tubes to ensure better safety, efficacy, and comfort for patients when the tube is inserted. Tympanostomy tubes should be made from biocompatible materials, such as silicon and titanium, which are less likely to cause infection or irritation when inserted. To avoid tube-related infections, manufacturers are focusing on antibiotic-eluting tubes, which would address the root cause of infections. Companies are also focusing on the development of self-expanding tubes to eliminate the need for a surgical procedure and anesthesia, making the procedure easier and quicker for healthcare providers as well as patients. Thus, technological advancements are likely to bring significant growth trends in the tympanostomy products market during the forecast period. Geographical Insights: In 2023, North America led the market with a substantial revenue share, followed by Europe and APAC. Asia Pacific is expected to register the highest CAGR during the forecast period. Competitive Strategy and Development Key Players: A few major companies operating in the tympanostomy products market include Olympus America, Medtronic, Summit Medical, GRACE MEDICAL, Preceptis Medical, Atos Medical, Medasil Surgical Ltd, Adept Medical Limited, Smith and Nephew Plc, Integra Life Science, and Karl Stroz SE & Co Kg. Trending Topics: Pediatric ENT Products, Telemedicine in ENT Care, Medical Devices and Implants, and Preventative Care Products Global Headlines on Tympanostomy Products Preceptis Medical Launches New Website to Support Increased Demand for Hummingbird In-Office Ear Tube Procedure Preceptis Medical Receives FDA Clearance for Expanded Labeling for Hummingbird System Smith+Nephew Announces Launch of Revolutionary Tula System in US for Placement of Ear Tubes Market Segmentation Based on product, the tympanostomy products market is bifurcated into tube applicators/inserters and tympanostomy tubes. The market for the tube applicators/inserters segment is further segmented into disposable and reusable. The tympanostomy tubes segment is further categorized into grommet, intermediate ear tubes, and t-shaped tubes. The tube applicators/inserters segment held a larger market share in 2023. By material, the tympanostomy products market is segmented into silicone, fluoroplastic, titanium, and stainless steel. The silicone segment held the largest market share in 2023. In terms of application, the tympanostomy products market is classified into acute otitis media, recurrent otitis media with effusion, and others. The acute otitis media segment held the largest market share in 2023. By end user, the market is fragmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment held the largest market share in 2023 The tympanostomy products market is segmented into five major regions: North America, Europe, APAC, Middle East and Africa, and South and Central America. Conclusion Ear health is an essential aspect of the overall well-being of the human body. Ear infections can lead to the impairment of hearing, spread of infection to skull and brain tissues and other nearby tissues, speech and developmental delays, tearing of the eardrum, and so on. Governments, regulatory bodies, and other organizations are taking initiatives to spread awareness about ear health. The World Health Organization (WHO) observes March 03 as World Hearing Day to raise awareness on how to decrease cases of deafness and hearing loss, and promote ear care globally. In addition, many committees are focusing on developing a roadmap to guide people to improve their ear health. The Hearing Health Sector Committee of the Australian Government developed the Roadmap for Hearing Health in 2019. Companies are focusing on the development of products that are made from biocompatible materials, such as silicone and titanium, which are less likely to cause infection or irritation when inserted. They are also working on the development of self-expanding tubes to eliminate the need for a surgical procedure and anesthesia, making the procedure easier and quicker for healthcare providers as well as patients. Thus, advancements in products and increasing awareness about ear health benefit the tympanostomy products market. The report from The Insight Partners, therefore, provides several stakeholders—including healthcare providers, product manufacturers, component manufacturers, and others—with valuable insights into how to successfully navigate this evolving market landscape and unlock new Reports: ENT Devices Market Size, Share, Trends, & Growth by 2030 Hearing Aids Market Share, Growth Drivers and Future Outlook Medical Device Coating Market Size, Share, Growth Report 2028 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit MathurE-mail: +1-646-491-9876 Site: Press Release- Sign in to access your portfolio
